Syndax Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript
All right. Thanks, everyone, for joining us at the Goldman Sachs Global Healthcare Conference. I'm glad you're all here even though the sun finally started shining, which is good news. Yes, we'll start out with we are required to make certain disclosures in public appearances about Goldman Sachs' relationship with the company that we discussed, the disclosures related to investment banking relationship, compensation received, or 1% or more ownership. We are prepared to read aloud disclosures for any issuer during the sessions upon your request. However, these disclosures are available in our most recent reports available to you as clients as clients on our firm's portal. In addition, a bit to those disclosures are available by ticker on the firm's public website. Goldman Sachs agreed to host this conference on the basis that no third-party seeker will provide confidential or material nonpublic information. In addition, by attending this conference, you provide Goldman Sachs right to record or redistribute the conference
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |